A Phase I Clinical Trial of RS001 in Patients with Relapsed/Refractory B-Cell Malignancies

NCT06894693 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

B-cell Non-Hodgkin's Lymphoma
Acute Lymphoblastic Leukemia

Interventions

BIOLOGICAL: RS001 injection

Sponsor

Guangdong Ruishun Biotech Co., Ltd